PharmEasy
PharmEasy is an Indian multinational e-pharmacy company that sells medicines, diagnostics and telehealth online. History 
The company was founded in 2015 by Dharmil Sheth and Dhaval Shah in Mumbai with the initial seed funding provided by their parents. The company wanted to expand beyond the Mumbai market and received their Series A funding. In May 2021, PharmEasy acquired rival e-pharmacy company Medlife for an undisclosed amount. In June 2021, the company acquired a 66.1% stake in diagnostics chain Thyrocare for . In September 2021, it acquired a majority stake in Aknamed, a healthcare supply chain company. In November 2021, the company filed papers to launch its initial public offering (IPO) of . The company withdrew its IPO plans in August 2022. Competition 
PharmEasy competes with other e-pharmacy companies including Netmeds (which was acquired by Reliance Industries), 1mg (acquired by Tata Group), Apollo 24x7 and Amazon Pharmacy. The Ken questioned the company's positioning as a unified healthtech player and referred to the company's story as "more confusing than convincing". Criticism

Medlife–PharmEasy merger protests
In 2020,  the two organizations were in merger talks which came to the attention of the Competition Commission of India (CCI) who were required to approve of the merger. The merger was protested by The South Chemist and Distributors Association (SCDA) who objected that such a merger should to be rejected as sales of medicines online was illegal in India. The online sales of medicines was later regulated and the merger was completed in 2021. PharmEasy advertisement
Members of the Hindu religion criticized one of the company's advertisements and said that religious sentiments were hurt for the sake of marketing and sales. The advertisement in question showed Lakshman being struck and Ram needing Sanjeevani and asking who will bring Sanjeevani from such a long distance. Two staff members of PharmEasy come on a scooter and delivers the medicine. 